In 2018, W.S.I. signed an exclusive distribution contract with Baxter, the No. 1 topical hemostatic matrix agent and manufacturer in Korea for Floseal. Moreover, based on its best sales staff and technology, the company achieved total sales of KRW 22 billion in medicines and medical devices.